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ABSTRACT
Microsatellite analysis is an important tool in clinical
research and molecular diagnostics because microsatellite
instability (MSI) occurs frequently in various types of
cancer. Approximately 10–15% of colorectal, gastric and
endometrial carcinomas are associated with MSI, and this
has an impact on clinical prognosis. The microsatellite loci
Bat25, Bat26, D2S123, D5S346 and D17S250, recom-
mended by the Bethesda guidelines, were analysed by
microfluidic-based on-chip electrophoresis in 40 cases of
colon carcinoma with known MSI status. In all cases,
microfluidic separation of the PCR amplicons resulted in
highly resolved, distinct patterns of each of the five
microsatellite loci. Detection of MSI could be demon-
strated by microsatellite-loci-associated, well-defined
deviations in the electropherogram profiles of tumour and
non-tumour material, and confirmed the classification of
MSI cases performed by conventional technology. In
conclusion, microfluidic chip technology is a simple and
reliable approach for MSI detection that allows label-free
and very fast analysis of microsatellite amplicons.
In 10–20% of patients with colorectal cancer
(CRC), carcinogenesis is due to genomic defects
in the mismatch repair machinery. Defective DNA
repair as a result of germ-line mutations has been
linked to sporadic colorectal carcinoma, and also to
those carcinomas arising in hereditary non-poly-
posis colorectal carcinoma (HNPCC) syndrome. In
both settings, the mutations and promoter hypo-
methylation occur mainly in the genes hMLH1 and
hMSH2 of the mismatch repair system, and result
in loss of their expression.
1 Further, defects in the
mismatch repair process with subsequent base pair
mismatches lead to microsatellite instability
(MSI).
12Since the failure of the repair system as
a cause of genomic instability is associated with a
better prognosis
13 many different microsatellite
loci have been used to identify MSI in tumours for
diagnostic and prognostic purposes.
2 In an attempt
to provide uniformity in clinical diagnoses, an
international meeting at the National Cancer
Institute (NCI) recommended primary microsatel-
lite markers for use in CRC MSI testing in clinical
and research settings. The recommended Bethesda
MSI testing set comprises the microsatellite loci
Bat25, Bat26, D2S123, D5S346 and D17S250,
characterised by mononucleotide and dinucleotide
repeats.
4
Different technologies have demonstrated their
applicability for MSI detection in the past, and
fluorochrome-based PCR assays linked to capillary
electrophoresisusing asequencing platformaremost
commonly used.
5 We have focused on the analysis of
microsatellite loci using microfluidic-based on-chip
electrophoresis, because recent studies have shown
microfluidics technology to be an electrophoresis
method with high-resolution capacity combined
with a short running time; these studies have been
reviewed.
6 In the present study, we investigate
microfluidic-based chip devices as an analytical
platform for MSI detection at all five loci known
as the Bethesda panel.
MATERIALS AND METHODS
Tissue material
Human CRC tissues were collected at the Institute
of Pathology, University Hospital of Cologne,
Germany, in accordance with local research ethical
guidelines. The tissues were fixed in formalin and
embedded in paraffin as per routine protocol. From
a panel of 150 colorectal carcinomas diagnosed
according to the Bethesda guidelines,
4 a total of 40
cases (14 MSI positive and 26 MSI negative) were
chosen to analyse the suitability of on-chip
electrophoresis for MSI diagnosis.
Two haematoxylin-stained sections (3 mm thick)
were evaluated by two pathologists, and tumour as
well as non-tumour areas were macrodissected
manually for further analyses.
DNA extraction and PCR
The macrodissected specimens were first depar-
affinised and then lysed overnight at 56uCb y
proteinase K digestion (500 mg/ml proteinase K,
5 mM EDTA, 20 mM Tris pH 8.0). The DNA was
extracted using a DNA-extraction kit from Qiagen
(Hilden, Germany) according to the manufac-
turer’s instructions. The DNA yield was between
10 and 30 ng/ml, determined by A260 measurement
using a Nanodrop spectrophotometer (PeqLab
Biotechnologie, Erlangen, Germany). DNA extracts
(2 ml) were applied in the Multiplex-PCR approach
of Qiagen according to the manufacturer’s instruc-
tions, using 60uC in the annealing step. The details
of the primer sets used for amplification of the
microsatellite loci Bat25, Bat26, D2S123, APC-
D5S346 and MFd15-D17S250 are shown in the
supplementary table S1.
25Primer sets of the Bat25
and the D2S123 loci, and of the D5S346 and the
D17S250 loci, were combined in duplex assays.
MSI analyses by on-chip electrophoresis
For the separation of microsatellite PCR pro-
ducts, we used DNA 1000 LabChip kits, which
are manufactured for research purposes only. In
brief, the chips were prepared with gel-dye mix,
pressurised, and then marker solution and DNA
1000 ladder were added. For this process, 1 mlo f
each PCR reaction was pipetted into one out of
12 sample wells of a prepared chip. After
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bioanalyser. The electrophoresis of 12 samples lasted approxi-
mately 30–40 min. Fragment analysis was carried out using
the Agilent 2100 expert software, and an overlay of two
electropherograms was used to compare PCR patterns derived
from tumour and non-tumour tissues. Differences in the
peak patterns of the overlaid electropherograms were
evaluated. Three overlays per patient were used in order to
identify instabilities in the microsatellite loci Bat25 and
D2S123, D5S346 and D17S250, and Bat26.
In order to compare the MSI analysis by the lab-on-a-chip
technology with a conventional method, loci were amplified
with fluorochrome-labelled primer sets and analysed on a
sequencing platform.
25
Figure 1 Overlay of electropherograms to classify the status of the five microsatellite loci. Electropherograms of microfluidic-based separation of
unlabelled PCR products representing each of the five microsatellite loci Bat25+D2S123, D5S346+D17S250 and Bat26 are shown. Bat25 and Bat26 are
mononucleotide repeats and D2S123, D5S346 and D17S250 are dinucleotide repeats. (A) The patterns of the electropherograms representing PCR
amplification products derived from normal tissue (red) and tumourous tissue (blue) are perfectly matching and demonstrate microsatellite stability.
However, the electropherogram overlays in (B) show significant deviations in the electrophoretic patterns of the microsatellite loci indicating
microsatellite instability (arrows indicate divergent pattern of peaks).
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Analysis of amplified microsatellite loci by microfluidic-based
on-chip electrophoresis
The microsatellite loci of the Bethesda panel, Bat25, Bat26,
D2S123, D5S346 and D17S250, recommended for CRC analyses
by the conference at NCI,
4 were amplified by label-free PCR. All
five amplified microsatellite loci, including mononucleotide and
dinucleotide repeats, were well resolved by microfluidic-based
on-chip electrophoresis (fig 1). Previous work of Banerjea et al
has shown that amplicons of the microsatellite locus Bat26 can
be analysed by microfluidic-based electrophoresis and that this
technology provides the advantage of being easy to use and
highly standardised because of microfabrication of the chips.
7 In
our study, the analysis of all five recommended microsatellite
loci took 15 min of preparation and no more than 30 min of
electrophoretic resolving time in comparison with conventional
procedures, which typically take between 4 and 6 h (see
supplementary table S2). The benefits of microfluidic-based
electrophoresis concerning low time and equipment operating
expenses have also been shown in other molecular diagnostic
approaches such as t(4,14) translocation,
8 mutation analyses
and quantification of promoter methylation.
9
In addition to previous studies, we demonstrate herein that
microfluidic-based analyses identify discrepancies in the micro-
satellite patterns between tumour and non-tumour DNA by the
overlay of electropherograms (fig 1). In 25 cases, the electro-
pherogram pattern of all five microsatellite amplicons from the
tumour DNA exactly corresponded to the pattern obtained
from non-tumour DNA (fig 1A), declaring the microsatellite
status of these cases as stable (MSS). On the other hand,
mismatches observed in the pattern of amplicons derived from
tumourous and non-tumourous tissues clearly indicate micro-
satellite instability (fig 1B). Therefore, the microfluidic-based
resolution appears to be an adequate technique to differentiate
stable and instable microsatellite loci.
Comparison of MSI analyses by microfluidic-based
electrophoresis with conventional methods
Taken together, the assessment of the MSI status by micro-
fluidic-based analysis shows more than 90% concordance with
the results of conventional fluorescence-based, laser-associated
detection methods. The MSI status of only two cases disagreed,
with the MSI analyses by on-chip microfluidic-technology
detecting an additional locus of instability in each case
(table 1). In such cases, additional clinical information or data
concerning the immunostaining of the repair enzymes hMLH1
and hMSH2 are helpful in deciding how to proceed further.
10 In
one discrepant case, negative immunostaining of the MLH1
repair enzyme pointed out that the MSI status proposed by the
microfluidic-based electrophoresis appeared to be the correct
interpretation.
These data demonstrate that the presented microfluidic-based
approach is a fast and reliable but also a very sensitive procedure
for MSI analyses in clinical studies. Microfluidic-based technol-
ogies have the advantage not to depend on a label and thus not
to require specialised procedures or equipment to detect the
label (see supplementary table S2). In contrast, most of the
conventional methods applied in MSI detection are dependent
on fluorochrome-labelling of PCR amplicon, and these are
subsequently analysed commonly by capillary electrophoresis
using laser-associated sequencing platforms.
In conclusion, the microfluidic-based approach for MSI
analyses is a highly time-efficient and easy procedure combined
with high sensitivity for MSI detection.
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Table 1 MSI status of colorectal carcinomas based on the results
obtained by microfluidic-based chip analyses in comparison to
prediagnosis
Samples, n
(%)
Prediagnosis by fluorescence-linked
PCR-approach and laser detection
Estimation by label-free
PCR and microfluidics
12 (30) MSI-H MSI-H
1* (2.5) MSI-L MSI-H
1 (2.5) MSI-L MSI-L
1* (2.5) MSS MSI-L
25 (62.5) MSS MSS
MSI, microsatellite instability; MSI-H, instability in more than one microsatellite locus
(*discrepant data between the techniques applied); MSI-L, instability in one
microsatellite locus; MSS, stability in all microsatellite loci.
Take home message
c Microfluidic-based on-chip electrophoresis enables very
reliable and sensitive evaluation of microsatellite instability.
Therefore, microfluidic-based chip electrophoresis is an
adequate procedure suitable for research laboratories and
fulfilling the Bethesda criteria for microsatellite instability
detection while saving time and technical efforts.
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